Clinical Trials Directory

Trials / Completed

CompletedNCT00146484

A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes

A Randomized Controlled Trial of Two Versus Three Daily Insulin Injections in Children and Adolescents With New Onset Type 1 Diabetes Mellitus

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
100 (planned)
Sponsor
Children's Hospital of Eastern Ontario · Academic / Other
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

The optimal insulin regimen for children and adolescents with newly diagnosed type 1 diabetes remains unknown. The purpose of this study is to determine whether a split evening injection regimen (insulin injections before breakfast, supper and bedtime) leads to better glucose control and quality of life than twice daily insulin in children and adolescents with new onset diabetes.

Detailed description

The optimal insulin regimen for children and adolescents with newly diagnosed type 1 diabetes remains unknown. No published studies have examined the effectiveness of a split evening (three times daily) injection regimen in this group of patients. Indeed, because the first few years of diabetes management are the easiest (due to a "honeymoon" period characterised by residual insulin secretion), the potential for any benefit from more intensive management (i.e., three daily injections) may be small during this period. In addition, the intensity of the initial insulin regimen may be an important determinant of quality of life, family functioning, and subsequent compliance with diabetes regimens. A randomized controlled trial has been designed to test the hypothesis that a split evening injection regimen leads to better glycemic control and quality of life than twice daily insulin in children and adolescents with new onset diabetes.

Conditions

Interventions

TypeNameDescription
DRUGTwice Daily versus Three Times Daily Insulin Injections

Timeline

Start date
1996-04-01
Completion
2001-01-01
First posted
2005-09-07
Last updated
2005-09-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00146484. Inclusion in this directory is not an endorsement.